FramptonJ.E., PloskerG.L.Icodextrin: a review of its use in peritoneal dialysis.Drugs2003; 63: 2079–105.
2.
KoningsCJAM, KoomanJ.P., SchonckM., GladziwaU., WirtzJ., van den Wall BakeA.W.Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.Kidney Int2003; 63: 1556–63.
3.
DaviesS.J., WoodrowG., DonovanK., PlumJ., WilliamsP., JohanssonA.C.Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.J Am Soc Nephrol2003; 14: 2338–44.
4.
DaviesS.J., BrownE.A., FrandsenN.E., RodriguesA.S., Rodriguez-CarmonaA., VychytilA.Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.Kidney Int2005; 67: 1609–15.
TintillierM., PochetJ.M., ChristopheJ.L., ScheiffJ.M., GoffinE.Transient sterile chemical peritonitis with icodextrin: clinical presentation, prevalence and literature review.Perit Dial Int2002; 22: 534–7.
7.
BoerW.H., VosP.F., FierenMWJA.Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis.Perit Dial Int2003; 23: 33–8.
8.
MartisL., PatelM., GiertychJ., MongovenJ., TaminneM., PerrierM.A.Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution.Lancet2005; 365: 588–94.
9.
MacGinleyR., CooneyK., AlexanderG., CohenS.M., GoldsmithD.J.A.Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.Am J Kidney Dis2002; 40: 1030–5.
10.
FoggensteinerL., BaylisJ., MossH., WilliamsP.Timely initiation of dialysis — single-exchange experience in 39 patients starting peritoneal dialysis.Perit Dial Int2002; 22: 471–6.
11.
WaradyB.Transient sterile chemical peritonitis in a CAPD patient using icodextrin [Letter].Perit Dial Int2002; 22: 90–1.
12.
PoulopoulosV., LamL., CugelmanA.Sterile peritonitis due to icodextrin: experience from a Canadian center.Perit Dial Int2004; 24: 88–9.
13.
TouréF., LavaudS., MohajerM., LavaudF., CanivetE., NguyenP.Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis.Kidney Int2004; 65: 654–60.
14.
GlorieuxG., LameireN., Van BiesenW., DequidtC., VanholderR.Specific characteristics of peritoneal leucocyte populations during sterile peritonitis associated with icodextrin CAPD fluids.Nephrol Dial Transplant2003; 18: 1648–53.
BasileC., De PadovaF., MontanaroA., GiordanoR.The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome.J Nephrol2003; 16: 384–6.
17.
EniaG., MandalariA., VenturaG., PustorinoD., PanuccioV.Sterile icodextrin-associated peritonitis may induce hypersensitivity and recurrent peritonitis on re-challenge.Nephrol Dial Transplant2003; 18: 626.
18.
PovlsenJ.V., IvarsenP., JorgensenK.A., MadsenS.Exposure to the peptidoglycan contaminant in icodextrin may cause sensitization of the patient maintained on peritoneal dialysis.Perit Dial Int2003; 23: 509–10.
